Albendazole

Active ingredient description

Αlbendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
P02CA03
Albendazole
P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Medicines

Albendazole is the active ingredient of these drugs:

Drug
Countries
ALBEL

Brazil

ALBENDOL

Singapore

ALBENTEL

Brazil

ALBENZA

United States

ALZENTAL

Singapore

ANDAZOL

Lithuania

ESKAZOLE

Australia Austria France Lithuania Netherlands

LUPIBEND

Lithuania

MEBENIX

Brazil

MONOZOL

Brazil

NEMACEST

Tunisia

PARASIN

Brazil

Z ZOLE

Tunisia

ZENDIS

Tunisia

ZENTEL

Australia France Singapore

ZESTAVAL

Cyprus

ZOLBEN

Brazil

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

F4216019LN - ALBENDAZOLE

CAS registry number

54965-21-8 - albendazole

SNOMED-CT

387558006 - Albendazole (substance)

Next: Usage